Uxin Limited (UXIN)
(Real Time Quote from BATS)
$3.73 USD
+0.90 (31.80%)
Updated Sep 27, 2024 12:06 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for Uxin Limited Sponsored ADR falls in the month of March.
All items in Millions except Per Share data.
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 3 | 14 | 22 | 36 | 113 |
Receivables | 3 | 2 | 26 | 37 | 48 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 15 | 16 | 67 | 11 | 1 |
Other Current Assets | 10 | 9 | 23 | 44 | 154 |
Total Current Assets | 31 | 41 | 138 | 127 | 316 |
Net Property & Equipment | 10 | 9 | 5 | 4 | 12 |
Investments & Advances | 39 | 42 | 46 | 44 | 39 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 1 |
Deposits & Other Assets | 0 | 0 | 4 | 6 | 0 |
Total Assets | 289 | 105 | 197 | 188 | 374 |
Liabilities & Shareholders Equity | 3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 11 | 12 | 15 | 15 | 19 |
Current Portion Long-Term Debt | 51 | 26 | 53 | 12 | 70 |
Current Portion Capital Leases | 7 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 51 | 50 | 137 | 146 | 341 |
Total Current Liabilities | 123 | 88 | 205 | 175 | 434 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 246 | 237 |
Long-Term Debt | 0 | 81 | 129 | 36 | 33 |
Non-Current Capital Leases | 165 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 21 | 110 | 100 | 31 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 330 | 290 | 436 | 493 | 705 |
Shareholders Equity | 3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 6 | 0 | 0 | 0 | 0 |
Capital Surplus | 2,622 | 2,250 | 2,249 | 2,090 | 1,841 |
Retained Earnings | -2,684 | -2,468 | -2,532 | -2,428 | -2,187 |
Other Equity | 16 | 32 | 45 | 33 | 15 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | -41 | -185 | -238 | -305 | -331 |
Total Liabilities & Shareholder's Equity | 289 | 105 | 197 | 188 | 374 |
Total Common Equity | -41 | -185 | -238 | -305 | -331 |
Shares Outstanding | 4.50 | 4.70 | 3.90 | 3.70 | 2.90 |
Book Value Per Share | -9.02 | -39.45 | -61.08 | -82.33 | -114.18 |
Fiscal Year End for Uxin Limited Sponsored ADR falls in the month of March.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 3 | 3 | 2 | 9 |
Receivables | NA | 3 | 3 | 3 | 2 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 15 | 16 | 25 | 16 |
Other Current Assets | NA | 10 | 11 | 9 | 9 |
Total Current Assets | NA | 31 | 33 | 39 | 35 |
Net Property & Equipment | NA | 10 | 10 | 10 | 9 |
Investments & Advances | NA | 39 | 41 | 40 | 40 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 0 | 0 | 0 | 0 |
Deposits & Other Assets | NA | 0 | 0 | 0 | 0 |
Total Assets | NA | 289 | 328 | 318 | 100 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 11 | 11 | 11 | 11 |
Current Portion Long-Term Debt | NA | 51 | 51 | 7 | 5 |
Current Portion Capital Leases | NA | 7 | 9 | 29 | 0 |
Accrued Expenses | NA | 0 | 0 | 0 | 0 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 51 | 53 | 53 | 57 |
Total Current Liabilities | NA | 123 | 125 | 100 | 73 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 40 | 40 |
Non-Current Capital Leases | NA | 165 | 193 | 186 | 0 |
Other Non-Current Liabilities | NA | 193 | 170 | 159 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 330 | 533 | 509 | 287 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 6 | 0 | 0 | 0 |
Capital Surplus | NA | 2,622 | 2,221 | 2,159 | 2,132 |
Retained Earnings | NA | -2,684 | -2,458 | -2,381 | -2,350 |
Other Equity | NA | 16 | 32 | 31 | 31 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | -41 | -206 | -191 | -186 |
Total Liabilities & Shareholder's Equity | NA | 289 | 328 | 318 | 100 |
Total Common Equity | 0 | -41 | -206 | -191 | -186 |
Shares Outstanding | 4.50 | 4.50 | 4.50 | 4.70 | 4.70 |
Book Value Per Share | 0.00 | -9.02 | -45.74 | -40.67 | -39.66 |